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Familial exudative vitreoretinopathy (FEVR) is an inherited blinding disorder of the retinal vascular system. Althoughmutations in three
genes (LRP5, FZD4, and NDP) are known to cause FEVR, these account for only a fraction of FEVR cases. The proteins encoded by these
FEVR genes form part of a signaling complex that activates the Norrin-b-catenin signaling pathway. Recently, through a large-scale
reverse genetic screen inmice, Junge and colleagues identiﬁed an additionalmember of this signaling complex, Tspan12. Here, we report
that mutations in TSPAN12 also cause autosomal-dominant FEVR. We describe seven mutations identiﬁed in a cohort of 70 FEVR
patients in whom we had already excluded the known FEVR genes. This study provides further evidence for the importance of the Nor-
rin-b-catenin signaling pathway in the development of the retinal vasculature and also indicates that more FEVR genes remain to be
identiﬁed.Familial exudative vitreoretinopathy (FEVR) is an inherited
disorder characterized by the incomplete development of
the retinal vasculature (MIM 133780).1 Its clinical appear-
ance varies considerably, even within families, with
severely affected patients often registered as blind during
infancy and mildly affected patients having few or no
visual problems. These mildly affected patients may have
only a small area of avascularity in their peripheral retina,
visible only by ﬂuorescein angiography, and patients
usually undergo this invasive exam only when a severely
affected family member is diagnosed. It is believed that
this peripheral avascularity is the primary anomaly in
FEVR and results from defective retinal angiogenesis. The
sight-threatening features of the FEVR phenotype are
considered secondary to retinal avascularity and develop
because of the resulting retinal ischemia. They include
the development of hyperpermeable blood vessels, neovas-
cularisation, vitreo-retinal traction, retinal folds, and
retinal detachments (Figure 1).2
FEVR is genetically heterogeneous and can be inherited
as a dominant, recessive, or X-linked trait. Three FEVR
genes have been identiﬁed to date: NDP (MIM 300658,
X-linked), FZD4 (MIM 604579, dominant), and LRP5
(MIM 603506, dominant and recessive).3–6 Mutation
screening of these genes suggests that they account for
less than half of all FEVR cases, indicating that additional
genes remain to be identiﬁed.7–12 However, only one addi-
tional locus has been mapped to chromosome 11p12-p13:
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been shown to participate in the same molecular pathway,
the Norrin-b-catenin signaling pathway.14,15 This pathway
is similar to the Wnt-b-catenin signaling pathway with the
exception that the Wnt ligand is replaced by Norrin, the
protein encoded byNDP. FZD4 and LRP5 encode the recep-
tors Frizzled-4 and low-density lipoprotein receptor-related
protein-5, and these two proteins act as coreceptors for
Wnts and Norrin. In the absence of the Wnt or Norrin
ligand, signaling is not activated in a cell. This results in
cytoplasmic b-catenin becoming phosphorylated and tar-
geted for degradation through the ubiquitin-proteasome
pathway. As a result, prospective target genes remain
repressed. Signaling is activated by Wnt or Norrin binding
at the cell surface to the Frizzled-4 and LRP5 receptor
complex. These receptors transduce a signal that inhibits
the destruction of b-catenin, allowing it to accumulate
within the cytoplasm. Subsequently, b-catenin translo-
cates to the nucleus, where it interacts with the Tcell factor
(TCF)/lymphoid enhancing factor (LEF) family of tran-
scription factors to turn on the expression of Wnt and/or
Norrin target genes.16
A number of mouse models of FEVR have been created
by disrupting the sequence of the FEVR genes.17–21 Studies
have shown that all of these mice have defects in the devel-
opment of the superﬁcial retinal vasculature and are
missing the two intraretinal capillary beds.21–24 Recently,
Junge and colleagues created Tspan12 mutant mice as
part of a large-scale reverse genetic screen and showedS9 7TF, UK; 2Department of Ophthalmology, Fukuoka University School of
l Institute of Bioregulation, Kyushu University, Fukuoka, Japan 812-8582;
sity of Western Australia, Perth, Australia 6009; 5Centre for Eye Research
e, Australia 3002; 6Department of Ophthalmology, Flinders Medical Centre,
heie Eye Institute, University of Pennsylvania School of Medicine, Philadel-
Hull HU3 2JZ, UK; 9Department of Ophthalmology, St Thomas’ Hospital,
Genetics.
12, 2010
Open access under CC BY license.
Figure 1. Clinical Appearance of FEVR
Fundus photograph of the right eye of the proband from family 1
(individual III:2 in Figure S1), showing the retinal vessels drawn up
in a retinal fold that is obscuring the macula.that they had a phenotype similar to that of the FEVR
mouse models.24 Prompted by this ﬁnding, they showed
that Tspan12 is a component of the Norrin-LRP5-FZD4
signaling complex and enhances the level of Norrin-b-cat-
enin signaling but not Wnt-b-catenin signaling.24
These results suggest that TSPAN12 (MIM 613138) on
chromosome 7q31.31 is an excellent candidate for involve-
ment in FEVR, and we therefore screened this gene in
a panel of 70 FEVR patients. Informed consent was
obtained from all subjects tested, and ethical approval
was obtained from the Leeds Teaching Hospitals Trust
Research Ethics Committee. We designed primers (see
Supplemental Data, available online) and screened all
seven coding exons and ﬂanking intronic sequences by
direct sequencing, using standard protocols. In total, we
discovered seven heterozygous TSPAN12 mutations not
present in controls (Figure 2).
We ﬁrst identiﬁed a 7 bp insertion in exon 4,
c.218_219insGCTCTTT, in an Australian family of Euro-
pean descent (family 1). This mutation causes a frame-
shift resulting in 45 incorrect amino acids after codon
72, followed by premature termination at codon 118
(p.F73LfsX118). The female proband in this family shows
macula ectopia, with a large retinal fold across the fovea
of her right eye and ﬁbrovascular changes in the temporal
periphery of her left eye (Figure 1). Her asymptomatic
father also carries themutation and has bilateral peripheral
retinal pigmentary disturbances that are reminiscent of
the bone-spicule pattern more commonly associated with
retinitis pigmentosa (Supplemental Data). This unusual
ﬁnding was interpreted as being old exudative retinal
detachments that have spontaneously resolved. The pro-
band’s asymptomatic brother was also found to carry the
mutation, but fundus examination revealed no signs ofThe Americadisease. However, he was only 10 yrs old when examined,
and fundus ﬂuorescein angiography was not performed, so
a mild phenotype could not be excluded.25
In a second family, originating from Japan (family 2), we
identiﬁed a nonsensemutation in exon 6, c.419T>A, segre-
gating with the disease. This mutation causes the TSPAN12
protein to be truncated from 305 amino acids to 139
(p.L140X). The female proband was diagnosed in infancy
with bilateral retinal folds. Her mutation-carrying father
is asymptomatic but has areas of avascularity and abnor-
mal vessels in the peripheral retina.
The third mutation identiﬁed was a nonsense change
in exon 3, c.68T>G, in an isolated FEVR patient from
the USA. This mutation is predicted to encode a signiﬁ-
cantly truncated protein of only 22 amino acids (p.L23X).
The patient is a 6-yr-old white female with bilateral retinal
folds and unilateral, persistent hyperplastic primary vit-
reous (persistent fetal vasculature). No DNA was available
from other family members, but none reported eye
problems.
The fourthmutation identiﬁed was a 5 bp deletion at the
end of intron 5, c.361-1_361-5delACCAG, in an isolated
FEVR patient from the UK. This mutation removes the
splice acceptor site including the consensus AG. The
precise effect of this mutation has not been determined
because RNAwas unavailable. However, possible outcomes
include the deletion of exon 6 (which would result in the
in-frame deletion of the 36 amino acids encoded by exon
6), the retention of intron 5 (whichwould result in a frame-
shift and premature-termination codon, p.P122SfsX125),
or the activation of an unknown cryptic splice site. The
white female patient had no family history of the disease
and was not diagnosed herself until the ﬁfth decade of
life. She has bilateral temporal retinal avascularity and
associated areas of exudation visible with fundus ﬂuores-
cein angiography. In addition, both eyes show traction of
the retinal vasculature at the posterior pole.
We identiﬁed a second putative splice-site mutation at
the start of intron 4, c.149þ3A>G, in an American family
originating from Europe (family 3). No RNA was available
for testing of the pathogenic nature of this DNA change,
but it was excluded from over 500 ethnically matched
control chromosomes. This mutation is in the splice donor
site at the end of exon 3, and the most common outcome
for these types of mutations is the deletion of the
preceding exon (which would result in a frameshift and
a premature-termination codon, p.L23GfsX88). The pro-
band of the family is an 8-yr-old female with bilateral
retinal folds affecting the macula. Her mutation-carrying
mother is asymptomatic but was noted to have bilateral
peripheral retinal pigment pallor, possibly indicating avas-
cularity. A maternal cousin, who also carries the mutation,
was diagnosed with a unilateral retinal fold in infancy. Her
mutation-carrying mother (proband’s maternal aunt)
showed no signs of FEVR, although she was not examined
by fundus ﬂuorescein angiography. A maternal uncle
was reported to have undergone a spontaneous retinaln Journal of Human Genetics 86, 248–253, February 12, 2010 249
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Figure 2. FEVR Is Caused by Mutations in TSPAN12
(A) Sequence traces of the seven mutations identiﬁed and the corresponding wild-type alleles.
(B) Schematic diagram of TSPAN12, showing the locations of the mutations.
(C) Schematic diagram of the TSPAN12 protein, showing the location of the mutations within the protein domains. The locations of the
transmembrane domains were obtained from Kovalenko et al., 2005.32 The intramolecular disulﬁde bonds crucial for the correct folding
of large extracellular loop are indicated by red dots. Because we were unable to assess the actual consequences of the two splicing muta-
tions, only predicted protein outcomes are shown.
250 The American Journal of Human Genetics 86, 248–253, February 12, 2010
  L101H 
 ↓ 
Human      86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Orangutan  86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Mouse      86 VKRNLLLLAWYFGTLLVIFCVELACGVWTYE 116 
Rat        86 VKRNLLLLAWYFGTLLVIFCVELACGVWTYE 116 
Cattle     86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Horse      86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Dog        86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Opossum    86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Chicken    86 VKRNLLLLVWYFGSLLVIFCVELACGVWTYE 116 
Zebrafinch 86 VKRNLLLLVWYFGSLLVIFCVELACGVWTYE 116 
Platypus   86 VKRNLLLLAWYFGSLLVIFCVELACGVWTYE 116 
Zebrafish  85 LKCNLLLLSWYFGSLMVIFCVELASGVWTYD 115 
Seasquirt  86 FTESQLLLGWFFFSMLVAFCVELSAGIWR-M 115 
    M210R 
  ↓ 
Human      198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Orangutan  198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Mouse      198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Rat        198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Cattle     198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Horse      198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Dog        198 LSDLYQ---EGCGKKMYSFLRGTKQLQVLRF 225 
Opossum    198 LSDLFQ---EGCGKKMYTFLRGTKQLQVLRF 225 
Chicken    198 LSDLYQ---EGCGKKMYTFLRGTKQLQVLRF 225 
Zebrafinch 198 LSDLYQ---EGCGKKMYTFLRGTKQLQVLRF 225 
Platypus   198 LSDLYQ---EGCGKKMYTFLRGTKQLQVLRF 225 
Zebrafish  195 LSDLYQ---EGCGPKIYSFIRGTKQLQVLRF 222 
Seasquirt  196 ACLDFISELDGCGTKLLADLSSPKSLASVPY 226 
Figure 3. Protein Sequence Alignment of Human TSPAN12 with
Its Orthologs
Alignments were calculated with ClustalW.33 Accession numbers:
Human, O95859; Orangutan, Q5R8B5; Mouse, AAH68240; Rat,
Q569A2; Cattle, Q29RH7; Horse, XP_001502093; Dog, XP_
855095; Opossum, XP_001364876; Chicken, XP_416007; Zebra-
ﬁnch, XP_002192381; Platypus, XP_001516347; Zebraﬁsh, NP_
957446; Seasquirt Tspan,12 XP_002123238. Only 30 amino acid
residues surrounding each mutation are shown. Conserved amino
acid residues are highlighted. The positions of the missense muta-
tions p.L101H and p.M210R are indicated.detachment at age 27, but no DNAwas available for check-
ing whether he carried the mutation.
The remaining two mutations were missense changes.
We identiﬁed p.L101H (c.302T>A) in exon 5 in a white
British family (family 4). The male proband and his father
both carried the mutation and showed classic signs of
FEVR, with the proband being severe and the father mild.
We identiﬁed p.M210R (c.629T > G) in exon 8 in a white
Australian male patient with bilateral retinal detachments.
This patient had no history of prematurity and presented at
5 yrs of age with a divergent squint. Upon examination he
was found to have bilateral macular traction and exudates
in the temporal retina. DNA was not available for family
members, but there is no reported family history of disease.
To exclude the possibility that these changeswere common
polymorphisms, we screened 200 ethnically matched
control individuals (400 chromosomes) for each of these
changes.26 We also checked each of the mutated amino
acids for conservation within orthologs of TSPAN12 (Fig-
ure 3). Both p.L101H and p.M210R are changes to highly
conserved residues, and bothmutations have negative Blo-
sum62 scores (3 and 1, respectively).27 Although these
results suggest that thesemissense changes are indeedpath-
ogenic, without further examination by means of a func-
tional assay, we are unable to categorically prove that they
are disease-causing mutations.
All types of mutations were identiﬁed (insertion, dele-
tion, nonsense, missense, and splicing), and at least four
of these are predicted to lead to transcripts with prema-
ture-termination codons that are likely to be targeted by
nonsense-mediated decay. Furthermore, there was no
difference in phenotype between the patients with trun-
cating mutations and those with missense changes. We
therefore propose that haploinsufﬁcency of TSPAN12 is
the cause of FEVR. From the clinical phenotypes observed
in the patients with TSPAN12 mutations, it is clear that
there is no correlation between particular mutations or
mutation types and phenotype for this form of FEVR.
The eye phenotypes vary in a manner similar to those
reported in FZD4, NDP, and LRP5 mutation carriers. LRP5
mutation carriers therefore remain the only subset of
FEVR patients that can be clinically distinguished by the
presence of low bone-mass density.5,9,28
TSPAN12 is a member of the tetraspanin superfamily, of
which there are 33 members in humans.29 Tetraspanins
contain four transmembrane domains with both the N
and C termini located in the cytoplasm. The transmem-
brane domains are linked by three loops: a small extracel-
lular loop, a large extracellular loop, and a tiny inner
loop (Figure 2C). Members of this protein family are char-
acterized by their ability to interact laterally with other tet-
raspanins and interacting proteins, thereby facilitating the
production of large multimolecular membrane complexes,
also called tetraspanin webs.30 Through a number of cell-
based assays and genetic interaction screens, Junge and
colleagues showed that TSPAN12 associates with the Nor-
rin-FZD4-LRP5 signaling complex and that this associationThe Americaresults in an increased level of Norrin-b-catenin signaling,
assayed with the Topﬂash reporter assay. Using the same
assay, they also showed that overexpression of TSPAN12
could rescue the reduction in b-catenin signaling observed
with either mutant Norrin or mutant FZD4 proteins
(p.C95R and p.M147V, respectively). On the basis of these
results, the authors hypothesize that Norrin and TSPAN12
cooperatively induce the multimerization of the FZD4-
LRP5 complex to induce b-catenin signaling.24 It is inter-
esting to note that both of the missense mutations identi-
ﬁed in this study are located in regions that are predicted to
play a role in tetraspanin homo- and heterodimerization,
indicating that they may disrupt the multimerization of
TSPAN12.31 The identiﬁcation of additional TSPAN12
mutations in the future will enable amore detailed analysis
of the domains of TSPAN12 that are functionally impor-
tant in Norrin-b-catenin signaling.
In summary, we have shown that heterozygous muta-
tions in TSPAN12 can cause autosomal-dominant FEVR.n Journal of Human Genetics 86, 248–253, February 12, 2010 251
Mutations in this gene accounted for 10% of FEVR cases in
our patient series, although this ﬁgure is inﬂated because
the majority of these patients had already been excluded
as carrying mutations in FZD4, LRP5, and NDP. This result
provides further evidence of signiﬁcant genetic heteroge-
neity in FEVR and indicates that other FEVR genes remain
to be found. In addition, this result conﬁrms the impor-
tance of the Norrin-b-catenin signaling pathway in the
development of the retinal vasculature and suggests that
the remaining FEVR genes will also be part of this new
signaling pathway.Supplemental Data
Supplemental Data include one ﬁgure and one table and can be
found with this article online at http://www.ajhg.org.Acknowledgments
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